Patterns of Antiplatelet Therapy in Patients Who Have Experienced an Acute Coronary Event: A Descriptive Study in UK Primary Care

Conclusion:
Although most patients were prescribed AP therapy in the 90 days following an acute coronary event, a substantial proportion discontinued DAT or ASA monotherapy within 1 year. It is essential that physicians consider strategies to reduce the risk of discontinuation of AP therapy.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - June 17, 2015 Category: Cardiology Authors: Saez, M. E., Gonzalez-Perez, A., Johansson, S., Nagy, P., Rodriguez, L. A. G. Tags: Clinical Studies Source Type: research